202 related articles for article (PubMed ID: 35774359)
1. ARL4C Regulates the Progression of Clear Cell Renal Cell Carcinoma by Affecting the Wnt/
Zhang P; Xu Y; Chen S; Wang Z; Zhao L; Chen C; Kang W; Han R; Qiu J; Wang Q; Gao H; Wu G; Xia Q
J Oncol; 2022; 2022():2724515. PubMed ID: 35774359
[TBL] [Abstract][Full Text] [Related]
2. TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro.
Xu Y; Wu G; Zhang J; Li J; Ruan N; Zhang J; Zhang Z; Chen Y; Zhang Q; Xia Q
Biomed Res Int; 2020; 2020():8409239. PubMed ID: 32908919
[TBL] [Abstract][Full Text] [Related]
3. A-kinase interacting protein 1 regulates the cell proliferation, invasion, migration and angiogenesis of clear cell renal cell carcinoma cells and affects the ERK/c-Myc signaling pathway by binding to Rac1.
Zhang Y; Zhang H; Han Z; Wang X; Li X; Yuan P; Ji S; Liu Q
Exp Ther Med; 2022 Sep; 24(3):558. PubMed ID: 35978938
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma.
Huang JL; Liao Y; Qiu MX; Li J; An Y
Tumour Biol; 2017 Jul; 39(7):1010428317711314. PubMed ID: 28718366
[TBL] [Abstract][Full Text] [Related]
6. TLN2 functions as a tumor suppressor in clear cell renal cell carcinoma via inactivation of the Wnt/β-catenin signaling pathway.
Cai J; Huang Z; Zhou J; Wu W; Ye Y
Transl Androl Urol; 2022 Jan; 11(1):39-52. PubMed ID: 35242640
[TBL] [Abstract][Full Text] [Related]
7. RUNX2 interacts with SCD1 and activates Wnt/β-catenin signaling pathway to promote the progression of clear cell renal cell carcinoma.
Song X; Liu J; Liu B; Piao C; Kong C; Li Z
Cancer Med; 2023 Mar; 12(5):5764-5780. PubMed ID: 36200301
[TBL] [Abstract][Full Text] [Related]
8. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
9. TNFAIP8 promotes the migration of clear cell renal cell carcinoma by regulating the EMT.
Zhong M; Zhu M; Liu Y; Lin Y; Wang L; Ye Y; Chen H; Yang Y; Zhuang G; Huang J
J Cancer; 2020; 11(10):3061-3071. PubMed ID: 32226521
[No Abstract] [Full Text] [Related]
10. CD56 polysialylation promotes the tumorigenesis and progression via the Hedgehog and Wnt/β-catenin signaling pathways in clear cell renal cell carcinoma.
Jian Y; Zhang L; Gong L; Ding M; Sun X; Yu X; Lv S; Li J; Yang D; Wang S
Cancer Cell Int; 2023 Dec; 23(1):319. PubMed ID: 38087309
[TBL] [Abstract][Full Text] [Related]
11. ESM-1 Mediates Cell Progression in Clear Cell Renal Cell Carcinoma by Affecting Wnt/β-Catenin Signalling Pathway.
Liu X; Wang F; Du W; Yang X
Arch Esp Urol; 2023 Jun; 76(4):290-297. PubMed ID: 37455528
[TBL] [Abstract][Full Text] [Related]
12. SOX17 Antagonizes the WNT Signaling Pathway and is Epigenetically Inactivated in Clear-Cell Renal Cell Carcinoma.
Wang L; Wang Z; Zhu Y; Tan S; Chen X; Yang X
Onco Targets Ther; 2021; 14():3383-3394. PubMed ID: 34079284
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin-specific protease 15 contributes to gastric cancer progression by regulating the Wnt/β-catenin signaling pathway.
Zhong M; Zhou L; Fang Z; Yao YY; Zou JP; Xiong JP; Xiang XJ; Deng J
World J Gastroenterol; 2021 Jul; 27(26):4221-4235. PubMed ID: 34326621
[TBL] [Abstract][Full Text] [Related]
14. SPRR3, a novel miR-338-3p target, regulates the malignant progression of clear cell renal cell carcinoma
Wu M; Guo Q; Liu X; Wu L
Exp Ther Med; 2022 May; 23(5):317. PubMed ID: 35350667
[TBL] [Abstract][Full Text] [Related]
15. The Role of
Liao J; Chen Z; Yu Z; Huang T; Hu D; Su Y; He Z; Zou C; Zhang L; Lin X
Front Oncol; 2020; 10():585292. PubMed ID: 33194732
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-like modifier activating enzyme 2 promotes cell migration and invasion through Wnt/β-catenin signaling in gastric cancer.
Li J; Sun X; He P; Liu WQ; Zou YB; Wang Q; Meng XW
World J Gastroenterol; 2018 Nov; 24(42):4773-4786. PubMed ID: 30479464
[TBL] [Abstract][Full Text] [Related]
17. NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/
Zhou J; Lai J; Cheng Y; Qu W
Evid Based Complement Alternat Med; 2022; 2022():1890823. PubMed ID: 36212952
[TBL] [Abstract][Full Text] [Related]
18. RAF1-MEK/ERK pathway-dependent ARL4C expression promotes ameloblastoma cell proliferation and osteoclast formation.
Fujii S; Ishibashi T; Kokura M; Fujimoto T; Matsumoto S; Shidara S; Kurppa KJ; Pape J; Caton J; Morgan PR; Heikinheimo K; Kikuchi A; Jimi E; Kiyoshima T
J Pathol; 2022 Jan; 256(1):119-133. PubMed ID: 34622442
[TBL] [Abstract][Full Text] [Related]
19. CUX1 Facilitates the Development of Oncogenic Properties
Feng F; Zhao Z; Zhou Y; Cheng Y; Wu X; Heng X
Front Mol Biosci; 2021; 8():705008. PubMed ID: 34422906
[No Abstract] [Full Text] [Related]
20. Epigenetic upregulation of ARL4C, due to DNA hypomethylation in the 3'-untranslated region, promotes tumorigenesis of lung squamous cell carcinoma.
Fujii S; Shinjo K; Matsumoto S; Harada T; Nojima S; Sato S; Usami Y; Toyosawa S; Morii E; Kondo Y; Kikuchi A
Oncotarget; 2016 Dec; 7(49):81571-81587. PubMed ID: 27835592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
